AZD0120

· AstraZeneca

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AZD0120, covering 2026-02-11 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of AZD0120 in Adults With Multiple Sclerosis [Phase 1]